Stockscreener 앱 받기
1.30
0.78%
0.01
시간 외 거래:
1.35
0.05
+3.85%
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stereotaxis Inc (STXS) Balance Sheet - TradingKey
Stereotaxis, Inc. Revenue Breakdown – AMEX:STXS - TradingView
Stereotaxis Inc. (STXS) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance UK
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan
Stereotaxis, Inc. opens new robotic EP laboratory in Hungary - Traders Union
University of Szeged Pioneers First Robotic Cardiology Program in Hungary - GlobeNewswire
University of Szeged Treats First Patients With Genesis System - Stock Titan
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings - Yahoo Finance
STXS Slides As Stereotaxis Clears Massive Secondary Share Block - timothysykes.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Stereotaxis Faces Integration, Financial, and Regulatory Challenges Following Robocath Acquisition - Minichart
Stereotaxis completes acquisition of Robocath; issues 6.27M shares, up to $25M earnout possible - TradingView
Stereotaxis (NYSE American: STXS) flags Robocath earnouts and 19.9% dilution - Stock Titan
Stereotaxis Files Resale Registration for Up to 108.9 Million Shares - Moomoo
Form S-3 Stereotaxis Inc For: 15 July By Investing.com - Investing.com Nigeria
Stereotaxis Finalizes Robocath Acquisition - dicardiology.com
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Stereotaxis closes Robocath takeover - MedTech Dive
Stereotaxis completes acquisition of Robocath By Investing.com - Investing.com India
Stereotaxis, Inc. completes Robocath acquisition to accelerate endovascular robotics expansion - Traders Union
Stereotaxis Closes $45M Deal for Robocath - Medical Product Outsourcing
Stereotaxis completes acquisition of Robocath - Investing.com
Robocath deal adds stock, warrants and earnouts at Stereotaxis (STXS) - Stock Titan
Stereotaxis Completes Acquisition of Robocath - GlobeNewswire
Stereotaxis folds Robocath into its surgical robotics platform - Stock Titan
Enterprise value to revenue forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Enterprise value to EBITDA forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Stereotaxis, Inc. completed the acquisition of Robocath SAS. - marketscreener.com
Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView
Price to book forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan
Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan
Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan
Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union
STXS Q1 2026 Earnings: EPS Misses Estimates as Stock SlipsWeak Earnings Momentum - dars.gov.et
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance
Stereotaxis Inc. (STXS) Holds Near Support Amidst Low VolatilityMomentum Stock Picks - dars.gov.et
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 3000 Value Benchmark - marketscreener.com
STXSStereotaxis Inc Options - Finviz
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2500 Value Benchmark - marketscreener.com
Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo
Stereotaxis (STXS) Gains 3.7% as Stock Hovers Near Key ResistanceSymmetrical Triangle - dars.gov.et
8 Most Promising Robotics Stocks Now - Insider Monkey
Enterprise value to EBIT forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView
STXS Q1 2026 Earnings: EPS Misses Estimates as Company Navigates Strategic TransitionQuarterly Financial Update - dars.gov.et
Stereotaxis, Inc. Actuals & Estimates (DUS:RJR1) - TradingView
STXS Forecast — Price Target — Prediction for 2027 - TradingView
Stereotaxis | 4: Statement of changes in beneficial ownership of securities-Officer Peery Kimberly R. - Moomoo
Stereotaxis Inc (STXS) Institutional Confidence - TradingKey
Stereotaxis, Inc. publishes new robotics case study in electrophysiology - Traders Union
Top Endovascular Robotic Systems Companies Driving the Future of Vascular Care - Fortune Business Insights
STXS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stereotaxis Inc. (STXS) Rallies Over 5% as Stock Tests Key Resistance at $1.97Intraday Trade Ideas - dars.gov.et
Stereotaxis, Inc. unveils online demo platform for advanced robotic cath lab - Traders Union
0.62%
0.03%
자본화:
|
볼륨(24시간):